The historic and groundbreaking two-day virtual meeting attracted more than 61,000 registrants from 140 countries. 0 59 0 obj <> endobj This article has been sent to my@email.address. May 29, 2020 - Jun 02, 2020.
Interview Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.We have sent a message to the email address you have provided, The email address you provided during registration, h�b```�����B �����3�~;00��1*��g`�h`�� �!Q(f`�b`�`:ð�a.C��O�L��0i0=ero�_�;g-CB"������ff��= �,��F�10�̓�2� ]� h�bbd```b``�"���"�j���`��dY�M�3��_0�&'�I0�DvhI��T;OlNH$�4خ� R�H��.��t�)�P�"�?�ѯ �Q Interview All fields are required. Search PracticeUpdate Cancel. Early breast cancer highlights from ASCO 2020 include refinement of adjuvant regimens in HER2+, selection of patients for chemo in ER+, and large-dose capecitabine maintenance in operable TNBC.
95 0 obj <>stream Copyright © 2020 Elsevier Inc. All rights reserved. The Coronavirus (COVID-19) has been impacting many facets of business, including Healthcare Conferences. The physical ASCO conference has been cancelled, however the research and work that was … Please make sure all fields are completed. %PDF-1.6 %���� SC142219 Email Article All set! ASCO’s growing roster of cutting-edge journals serves readers as the most credible, authoritative, peer-reviewed resources for significant clinical oncology research and research that informs the delivery of efficient, high-quality cancer care across the globe. A Message to PracticeUpdate Users Regarding the ASCO Conference Cancellation. Answers to questions about COVID-19 published herein are provided by the American Society of Clinical Oncology, Inc. (“ASCO”) for voluntary, informational use by providers in the rapidly evolving novel coronavirus crisis. PracticeUpdate Editorial Team Interview Indiana University School of Medicine, Continuing Medical Education , Review and Interpretation of the 2020 ASCO Review, 7/18/2020 8:00:00 AM - 7/18/2020 1:30:00 PM, This symposium will include 20-30 minute lectures which review the clinical trial data reported at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in 2020. 82 0 obj <>/Filter/FlateDecode/ID[<341DC4535C1B5A42B79350B97829502B><5D881F526808644EA509991E270FC4BB>]/Index[59 37]/Info 58 0 R/Length 110/Prev 157669/Root 60 0 R/Size 96/Type/XRef/W[1 3 1]>>stream endstream endobj 60 0 obj < American Society of Clinical Oncology. To learn more, please visit our PracticeUpdate® is a registered trademark of Elsevier Inc. ASCO reserves the right to cancel the Meeting due to unforeseen circumstances. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer–Related Lymphedema and Local Tumor ControlAvelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent ChemotherapyResidual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients With HR+/HER2− Breast CancerT-DM1 in Patients With HER2-Positive Metastatic Breast Cancer and Brain MetastasesLong-Term Overall Survival and Toxicities of ABVD vs BEACOPP in Advanced Hodgkin LymphomaRituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell LymphomaFDA Approves First Liquid Biopsy Next-Generation Sequencing Companion Diagnostic TestStem Cell Transplantation and Vinblastine Monotherapy for Relapsed Pediatric Anaplastic Large Cell Lymphoma By attending the Meeting or logging into the Meeting ’s website(s) or application(s) and engaging in any interactive features, you agree that ASCO and/or third parties … Search × 2020 ASCO Annual Meeting. CANCELLATION . For multiple recipients, separate email addresses with a semicolon. PracticeUpdate Editorial Team Interview endstream endobj startxref